Trump's long -
awaited plan to bring down drug prices, unveiled Friday, will mostly spare the pharmaceutical
industry he previously accused of «getting away with murder» and instead focus on increasing private competition and requiring more openness about costs.
Free schools, new academies and the James Review were all popular topics of conversation and the subject of much debate throughout BSEC 2011, whilst the
industry still
awaits Michael Gove's capital spending
plans now expected in June.